Clinical pharmacology

Group of educational programs: R042 Clinical pharmacology

Cipher: 7R01109

Duration of study: 2 years, 140 credits

Admission conditions: higher medical education, internship, or a document demonstrating the qualification of the «doctor» under the program of higher medical education, doctor's certificate, entrance exam in accordance with the Admission Policy

Tuition fee for 1 year: 2 000 000 tenge

Policy of admission
Clinical pharmacology
Kalieva Sholpan Sabataevna
Kalieva Sholpan Sabataevna
Head of educational program
S-Kalieva@qmu.kz
+7 7212 503930, int.1224
More detailed

Mission

Training highly qualified specialists with in-depth knowledge in the field of clinical pharmacology, who are able to apply and develop advanced innovative technologies in medicine, science and practice, based on the principles of evidence-based medicine and to respond to needs of society in the high quality of medical services and treatment results

What will you learn?

1st course
  • Work with the main regulatory legal acts in the field of circulation of medicines.
  • Participate in improving and maintaining the formulary system in medical organizations
  • Analyze and formulate the need for medicines within the framework of the guaranteed volume of medical care, compulsory medical insurance, paid services
  • Conduct an assessment of the use of medicines in a healthcare organization (ABC, VEN tests, needs analysis).
  • Create a medicinal formulary for a medical organization based on the KNF.
  • Assess and select the most effective, safe and economically sound drugs for the treatment of adults and children, using international and national databases of evidence-based medical information.
  • Plan the use of antimicrobial agents and participate in the development of measures to curb antibiotic resistance together with infection control specialists of the medical organization
  • Conduct a search and analysis of international clinical guidelines, analyze current national clinical protocols (CP), effectively adapt and update the CP to the national healthcare system based on international and national recommendations for best clinical practice.
2nd course
  • Conduct rational pharmacotherapy based on the choice of drugs, taking into account proven clinical and economic effectiveness, drug safety, pathological and physiological profile of the patient using international guidelines and clinical protocols.
  • Correlate risk factors and predict the likelihood of clinical manifestations of adverse drug reactions
  • Participate in pharmacovigilance
  • Provide advisory assistance to patients and doctors on issues of rational choice and personalized use of medicines based on the analysis of international data and recommendations of national clinical guidelines, taking into account the physiological and pathological profile of patients, including pregnant and lactating women, children, elderly patients, severe comorbid patients with renal disease and liver failure.
  • Diagnose and provide emergency care in case of emergency conditions.
  • Participate in conducting a clinical audit, organizing and planning a drug evaluation program in a medical organization.
  • Be familiar with the regulations governing the conduct of clinical trials in the Republic of Kazakhstan.
  • Conduct data collection and assessment and work with clinical trial registries
  • Participate in clinical trials/medicine trials